Alcohol
Volume 35, Issue 3 , Pages 213-225 , April 2005

The etiology of alcohol-induced breast cancer

Received 11 April 2005 ,Accepted 23 April 2005.

References 

  1. Ahsan H, Chen Y, Whittemore AS, Kibriya MG, Gurvich I, Senie RT, et al. A family-based genetic association study of variants in estrogen-metabolism genes COMT and CYP1B1 and breast cancer risk. Breast Cancer Res Treat. 2004;85:121–131
  2. Albano E, Clot P, Comoglio A, Dianzani MU, Tomasi A. Free radical activation of acetaldehyde and its role in protein alkylation. FEBS Lett. 1994;348:65–69
  3. Albano E, Clot P, Morimoto M, Tomasi A, Ingelman-Sundberg M, French SW. Role of cytochrome P4502E1-dependent formation of hydroxyethyl free radical in the development of liver damage in rats intragastrically fed with ethanol. Hepatology. 1996;23:155–163
  4. Ambrosone CB. Oxidants and antioxidants in breast cancer. Antioxid Redox Signal. 2000;2:903–917
  5. Ambrosone CB, Freudenheim JL, Thompson PA, Bowman E, Vena JE, Marshall JR, et al. Manganese superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants, and risk of breast cancer. Cancer Res. 1999;59:602–606
  6. American Cancer Society . Cancer Facts and Figures 2005. Atlanta: Author; 2005;Available at http://www.cancer.org/downloads/STT/CAFF2005f4PWSecured.pdf
  7. Bailey LB. Folate, methyl-related nutrients, alcohol, and the MTHFR 677C→T polymorphism affect cancer risk: intake recommendations. J Nutr. 2003;133:3748S–3753S
  8. Bailey LB, Gregory JF. Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: metabolic significance, risks and impact on folate requirement. J Nutr. 1999;129:919–922
  9. Bailey LR, Roodi N, Dupont WD, Parl FF. Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer. Cancer Res. 1998;58:5038–5041
  10. Barnes SL, Singletary KW, Frey R. Ethanol and acetaldehyde enhance benzo[a]pyrene–DNA adduct formation in human mammary epithelial cells. Carcinogenesis. 2000;21:2123–2128
  11. Bianchi MS, Bianchi NO, Bailliet G. Mitochondrial DNA mutations in normal and tumor tissues from breast cancer patients. Cytogenet Cell Genet. 1995;71:99–103
  12. Bird RP, Draper HH, Basrur PK. Effect of malonaldehyde and acetaldehyde on cultured mammalian cells. Production of micronuclei and chromosomal aberrations. Mutat Res. 1982;101:237–246
  13. Blasiak J. Ethanol and acetaldehyde impair the repair of bleomycin-damaged DNA in human lymphocytes. Cytobios 106 Suppl. 2001;2:141–149
  14. Blasiak J, Trzeciak A, Malecka-Panas E, Drzewoski J, Wojewodzka M. In vitro genotoxicity of ethanol and acetaldehyde in human lymphocytes and the gastrointestinal tract mucosa cells. Toxicol In Vitro. 2000;14:287–295
  15. Blaszyk H, Vaughn CB, Hartmann A, McGovern RM, Schroeder JJ, Cunningham J, et al. Novel pattern of p53 gene mutations in an American black cohort with high mortality from breast cancer. Lancet. 1994;343:1195–1197
  16. Blount BC, Mack MM, Wehr CM, MacGregor JT, Hiatt RA, Wang G, et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci U S A. 1997;94:3290–3295
  17. Boyd NF, Byng JW, Jong RA, Fishell EK, Little LE, Miller AB, et al. Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst. 1995;87:670–675
  18. Boyd NF, Connelly P, Byng J, Yaffe M, Draper H, Little L, et al. Plasma lipids, lipoproteins, and mammographic densities. Cancer Epidemiol Biomarkers Prev. 1995;4:727–733
  19. Branda RF, Brooks EM, Chen Z, Naud SJ, Nicklas JA. Dietary modulation of mitochondrial DNA deletions and copy number after chemotherapy in rats. Mutat Res. 2002;501:29–36
  20. Byrne C, Schairer C, Brinton LA, Wolfe J, Parekh N, Salane M, et al. Effects of mammographic density and benign breast disease on breast cancer risk (United States). Cancer Causes Control. 2001;12:103–110
  21. Castro GD, Delgado de Layno AM, Costantini MH, Castro JA. Cytosolic xanthine oxidoreductase mediated bioactivation of ethanol to acetaldehyde and free radicals in rat breast tissue. Its potential role in alcohol-promoted mammary cancer. Toxicology. 2001;160:11–18
  22. Chacko P, Joseph T, Mathew BS, Rajan B, Pillai MR. Role of xenobiotic metabolizing gene polymorphisms in breast cancer susceptibility and treatment outcome. Mutat Res. 2005;581:153–163
  23. Chen F-M, Hou M-F, Wang J-Y, Chen T-c, Chen DCP, Huang S-Y, et al. High frequency of G/C transversion on p53 gene alterations in breast cancers from Taiwan. Cancer Lett. 2004;207:59–67
  24. Chen J, Gammon MD, Chan W, Palomeque C, Wetmur JG, Kabat GC, et al. One-carbon metabolism, MTHFR polymorphisms, and risk of breast cancer. Cancer Res. 2005;65:1606–1614
  25. Chen J, Petersen DR, Schenker S, Henderson GI. Formation of malondialdehyde adducts in livers of rats exposed to ethanol: role in ethanol-mediated inhibition of cytochrome c oxidase. Alcohol Clin Exp Res. 2000;24:544–552
  26. Choi J-Y, Abel J, Neuhaus T, Ko Y, Harth V, Hamajima N, et al. Role of alcohol and genetic polymorphisms of CYP2E1 and ALDH2 in breast cancer development. Pharmacogenetics. 2003;13:67–72
  27. Choi S-W, Stickel F, Baik HW, Kim Y-I, Seitz HK, Mason JB. Chronic alcohol consumption induces genomic but not p53-specific DNA hypomethylation in rat colon. J Nutr. 1999;129:1945–1950
  28. Cooper GS, Sandler DP, Whelan EA, Smith KR. Association of physical and behavioral characteristics with menstrual cycle patterns in women age 29–31 years. Epidemiology. 1996;7:624–628
  29. Coutelle C, Hohn B, Benesova M, Oneta CM, Quattrochi P, Roth HJ, et al. Risk factors in alcohol associated breast cancer: alcohol dehydrogenase polymorphism and estrogens. Int J Oncol. 2004;25:1127–1132
  30. Dellarco VL. A mutagenicity assessment of acetaldehyde. Mutat Res. 1988;195:1–20
  31. Denissenko MF, Chen JX, Tang M-s, Pfeifer GP. Cytosine methylation determines hot spots of DNA damage in the human P53 gene. Proc Natl Acad Sci U S A. 1997;94:3893–3898
  32. Destro-Bisol G, Vienna A, Battaggia C, Paoli G, Spedini G. Testing a biochemical model of human genetic resistance to falciparum malaria by the analysis of variation at protein and microsatellite loci. Hum Biol. 1999;71:315–332
  33. De Vivo I, Hankinson SE, Li L, Colditz GA, Hunter DJ. Association of CYP1B1 polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2002;11:489–492
  34. Divine KK, Gilliland FD, Crowell RE, Stidley CA, Bocklage TJ, Cook DL, et al. The XRCC1 399 glutamine allele is a risk factor for adenocarcinoma of the lung. Mutat Res. 2001;461:273–278
  35. Duell EJ, Millikan RC, Pittman GS, Winkel S, Lunn RM, Tse C-KJ, et al. Polymorphisms in the DNA repair gene XRCC1 and breast cancer. Cancer Epidemiol Biomarkers Prev. 2001;10:217–222
  36. Dulout FN, Furnus CC. Acetaldehyde-induced aneuploidy in cultured Chinese hamster cells. Mutagenesis. 1988;3:207–211
  37. Dunn BK, Wickerham DL, Ford LG. Prevention of hormone-related cancers: breast cancer. J Clin Oncol. 2005;23:357–367
  38. Dupont I, Lucas D, Clot P, Menez C, Albano E. Cytochrome P4502E1 inducibility and hydroxyethyl radical formation among alcoholics. J Hepatol. 1998;28:564–571
  39. Duthie SJ. Folic acid deficiency and cancer: mechanisms of DNA instability. Br Med Bull. 1999;55:578–592
  40. Dybdahl M, Vogel U, Frentz G, Wallin H, Nexø BA. Polymorphisms in the DNA repair gene XPD: correlations with risk and age at onset of basal cell carcinoma. Cancer Epidemiol Biomarkers Prev. 1999;8:77–81
  41. Edenberg HJ, Jerome RE, Li M. Polymorphism of the human alcohol dehydrogenase 4 (ADH4) promoter affects gene expression. Pharmacogenetics. 1999;9:25–30
  42. Ellison RC, Zhang Y, McLennan CE, Rothman KJ. Exploring the relation of alcohol consumption to risk of breast cancer. Am J Epidemiol. 2001;154:740–747
  43. El-Rayes BF, Ali S, Heilbrun LK, Lababidi S, Bouwman D, Visscher D, et al. Cytochrome P450 and glutathione transferase expression in human breast cancer. Clin Cancer Res. 2003;9:1705–1709
  44. The Endogenous Hormones and Breast Cancer Collaborative Group . Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst. 2002;94:606–616
  45. Enger SM, Ross RK, Paganini-Hill A, Longnecker MP, Bernstein L. Alcohol consumption and breast cancer oestrogen and progesterone receptor status. Br J Cancer. 1999;79:1308–1314
  46. Espina N, Lima V, Lieber CS, Garro AJ. In vitro and in vivo inhibitory effect of ethanol and acetaldehyde on O6-methylguanine transferase. Carcinogenesis. 1988;9:761–766
  47. Etique N, Chardard D, Chesnel A, Merlin J-L, Flament S, Grillier-Vuissoz I. Ethanol stimulates proliferation, ERα and aromatase expression in MCF-7 human breast cancer cells. Int J Mol Med. 2004;13:149–155
  48. Fan S, Meng Q, Gao B, Grossman J, Yadegari M, Goldberg ID, et al. Alcohol stimulates estrogen receptor signaling in human breast cancer cell lines. Cancer Res. 2000;60:5635–5639
  49. Feigelson HS, Coetzee GA, Kolonel LN, Ross RK, Henderson BE. A polymorphism in the CYP17 gene increases the risk of breast cancer. Cancer Res. 1997;57:1063–1065
  50. Freedman M, San Martin J, O'Gorman J, Eckert S, Lippman ME, Lo S-CB, et al. Digitized mammography: a clinical trial of postmenopausal women randomly assigned to receive raloxifene, estrogen, or placebo. J Natl Cancer Inst. 2001;93:51–56
  51. Freudenheim JL, Ambrosone CB, Moysich KB, Vena JE, Graham S, Marshall JR, et al. Alcohol dehydrogenase 3 genotype modification of the association of alcohol consumption with breast cancer risk. Cancer Causes Control. 1999;10:369–377
  52. Freudenheim JL, Bonner M, Krishnan S, Ambrosone CB, Graham S, McCann SE, et al. Diet and alcohol consumption in relation to p53 mutations in breast tumors. Carcinogenesis. 2004;25:931–939
  53. Friso S, Choi S-W. Gene-nutrient interactions and DNA methylation. J Nutr. 2002;132:2382S–2387S
  54. Friso S, Choi S-W, Girelli D, Mason JB, Dolnikowski GG, Bagley PJ, et al. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci U S A. 2002;99:5606–5611
  55. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10:111–113
  56. Gammon MD, Hibshoosh H, Terry MB, Bose S, Schoenberg JB, Brinton LA, et al. Cigarette smoking and other risk factors in relation to p53 expression in breast cancer among young women. Cancer Epidemiol Biomarkers Prev. 1999;8:255–263
  57. Gapstur SM, Potter JD, Drinkard C, Folsom AR. Synergistic effect between alcohol and estrogen replacement therapy on risk of breast cancer differs by estrogen/progesterone receptor status in the Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev. 1995;4:313–318
  58. Garro AJ, McBeth DL, Lima V, Lieber CS. Ethanol consumption inhibits fetal DNA methylation in mice: implications for the fetal alcohol syndrome. Alcohol Clin Exp Res. 1991;15:395–398
  59. Ginsburg ES. Estrogen, alcohol and breast cancer risk. J Steroid Biochem Mol Biol. 1999;69:299–306
  60. Giovannucci E. Alcohol, one-carbon metabolism, and colorectal cancer: recent insights from molecular studies. J Nutr. 2004;134:2475S–2481S
  61. Goodman JE, Lavigne JA, Wu K, Helzlsouer KJ, Strickland PT, Selhub J, et al. COMT genotype, micronutrients in the folate metabolic pathway and breast cancer risk. Carcinogenesis. 2001;22:1661–1665
  62. Haiman CA, Hankinson SE, De Vivo I, Guillemette C, Ishibe N, Hunter DJ, et al. Polymorphisms in steroid hormone pathway genes and mammographic density. Breast Cancer Res Treat. 2003;77:27–36
  63. Halsted CH, Villanueva JA, Devlin AM, Niemelä O, Parkkila S, Garrow TA, et al. Folate deficiency disturbs hepatic methionine metabolism and promotes liver injury in the ethanol-fed micropig. Proc Natl Acad Sci U S A. 2002;99:10072–10077
  64. Hamajima N, Hirose K, Tajima K, Rohan T, Calle EE, Heath CW, et al. Alcohol, tobacco and breast cancer – collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer. 2002;87:1234–1245
  65. Han W, Kang D, Park IA, Kim SW, Bae JY, Chung K-W, et al. Associations between breast cancer susceptibility gene polymorphisms and clinicopathological features. Clin Cancer Res. 2004;10:124–130
  66. Hanna IH, Dawling S, Roodi N, Guengerich FP, Parl FF. Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity. Cancer Res. 2000;60:3440–3444
  67. Harmon DL, Shields DC, Woodside JV, McMaster D, Yarnell JWG, Young IS, et al. Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations. Genet Epidemiol. 1999;17:298–309
  68. Hartmann A, Blaszyk H, Kovach JS, Sommer SS. The molecular epidemiology of P53 gene mutations in human breast cancer. Trends Genet. 1997;13:27–33
  69. Harty LC, Caporaso NE, Hayes RB, Winn DM, Bravo-Otero E, Blot WJ, et al. Alcohol dehydrogenase 3 genotype and risk of oral cavity and pharyngeal cancers. J Natl Cancer Inst. 1997;89:1698–1705
  70. Hellmold H, Rylander T, Magnusson M, Reihner E, Warner M, Gustafsson J-A. Characterization of cytochrome P450 enzymes in human breast tissue from reduction mammaplasties. J Clin Endocrinol Metab. 1998;83:886–895
  71. Hines LM, Hankinson SE, Smith-Warner SA, Spiegelman D, Kelsey KT, Colditz GA, et al. A prospective study of the effect of alcohol consumption and ADH3 genotype on plasma steroid hormone levels and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2000;9:1099–1105
  72. Hoek JB, Cahill A, Pastorino JG. Alcohol and mitochondria: a dysfunctional relationship. Gastroenterology. 2002;122:2049–2063
  73. Hsieh L-L, Chien H-T, Chen I-H, Liao C-T, Wang H-M, Jung S-M, et al. The XRCC1 399Gln polymorphism and the frequency of p53 mutations in Taiwanese oral squamous cell carcinomas. Cancer Epidemiol Biomarkers Prev. 2003;12:439–443
  74. Hu YJ, Diamond AM. Role of glutathione peroxidase 1 in breast cancer: loss of heterozygosity and allelic differences in the response to selenium. Cancer Res. 2003;63:3347–3351
  75. Huang C-S, Chern H-D, Chang K-J, Cheng C-W, Hsu S-M, Shen C-Y. Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility. Cancer Res. 1999;59:4870–4875
  76. International Agency for Research on Cancer . IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 36: Allyl Compounds, Aldehydes, Epoxides and Peroxides (189–226). Lyon, France: IARC Press; 1985;Available at http://www-cie.iarc.fr/htdocs/indexes/vol36index.html
  77. Iscan M, Klaavuniemi T, Çoban T, Kapucuoğlu N, Pelkonen O, Raunio H. The expression of cytochrome P450 enzymes in human breast tumours and normal breast tissue. Breast Cancer Res Treat. 2001;70:47–54
  78. Ishii H, Kurose I, Kato S. Pathogenesis of alcoholic liver disease with particular emphasis on oxidative stress. J Gastroenterol Hepatol. 1997;12:S272–S282
  79. Jeong K-S, Soh Y, Jeng J, Felder MR, Hardwick JP, Song BJ. Cytochrome P450 2E1 (CYP2E1)-dependent production of a 37-kDa acetaldehyde–protein adduct in the rat liver. Arch Biochem Biophys. 2000;384:81–87
  80. Kapucuoglu N, Coban T, Raunio H, Pelkonen O, Edwards RJ, Boobis AR, et al. Immunohistochemical demonstration of the expression of CYP2E1 in human breast tumour and non-tumour tissues. Cancer Lett. 2003;196:153–159
  81. Kim Y-I, Shirwadkar S, Choi S-W, Puchyr M, Wang Y, Mason JB. Effects of dietary folate on DNA strand breaks within mutation-prone exons of the p53 gene in rat colon. Gastroenterology. 2000;119:151–161
  82. Koch OR, Pani G, Borrello S, Colavitti R, Cravero A, Farrè S, et al. Oxidative stress and antioxidant defenses in ethanol-induced cell injury. Mol Aspects Med. 2004;25:191–198
  83. Kohen R, Nyska A. Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol Pathol. 2002;30:620–650
  84. Kuykendall JR, Bogdanffy MS. Formation and stability of acetaldehyde-induced crosslinks between poly-lysine and poly-deoxyguanosine. Mutat Res. 1994;311:49–56
  85. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics. 1996;6:243–250
  86. Lai H, Lai S, Ma F, Meng L, Trapido E. Prevalence and spectrum of p53 mutations in white Hispanic and non-Hispanic women with breast cancer. Breast Cancer Res Treat. 2003;81:53–60
  87. Lai JH, Vesprini D, Zhang W, Yaffe MJ, Pollak M, Narod SA. A polymorphic locus in the promoter region of the IGFBP3 gene is related to mammographic breast density. Cancer Epidemiol Biomarkers Prev. 2004;13:573–582
  88. Lambrinakos A, Yakubovskaya M, Babon JJ, Neschastnova AA, Vishnevskaya YV, Belitsky GA, et al. Novel TP53 gene mutations in tumors of Russian patients with breast cancer detected using a new solid phase chemical cleavage of mismatch method and identified by sequencing. Hum Mutat. 2004;23:186–192
  89. Laufer EM, Hartman TJ, Baer DJ, Gunter EW, Dorgan JF, Campbell WS, et al. Effects of moderate alcohol consumption on folate and vitamin B12 status in postmenopausal women. Eur J Clin Nutr. 2004;58:1518–1524
  90. Leclerc D, Campeau E, Goyette P, Adjalla CE, Christensen B, Ross M, et al. Human methionine synthase: cDNA cloning and identification of mutations in patients of the cblG complementation group of folate/cobalamin disorders. Hum Mol Genet. 1996;5:1867–1874
  91. Le Marchand L, Haiman CA, Wilkens LR, Kolonel LN, Henderson BE. MTHFR polymorphisms, diet, HRT, and breast cancer risk: The Multiethnic Cohort Study. Cancer Epidemiol Biomarkers Prev. 2004;13:2071–2077
  92. Li CI, Malone KE, Porter PL, Weiss NS, Tang M-TC, Daling JR. The relationship between alcohol use and risk of breast cancer by histology and hormone receptor status among women 65–79 years of age. Cancer Epidemiol Biomarkers Prev. 2003;12:1061–1066
  93. Li D, Zhang W, Sahin AA, Hittelman WN. DNA adducts in normal tissue adjacent to breast cancer: a review. Cancer Detect Prev. 1999;23:454–462
  94. Li Y, Millikan RC, Bell DA, Cui L, Tse C-KJ, Newman B, et al. Cigarette smoking, cytochrome P4501A1 polymorphisms, and breast cancer among African-American and white women. Breast Cancer Res. 2004;6:R460–R473
  95. Lieber CS. Role of oxidative stress and antioxidant therapy in alcoholic and nonalcoholic liver diseases. Adv Pharmacol. 1997;38:601–628
  96. Lubec G. The hydroxyl radical: from chemistry to human disease. J Investig Med. 1996;44:324–346
  97. Lunn RM, Helzlsouer KJ, Parshad R, Umbach DM, Harris EL, Sanford KK, et al. XPD polymorphisms: effects on DNA repair proficiency. Carcinogenesis. 2000;21:551–555
  98. Ma J, Stampfer MJ, Christensen B, Giovannucci E, Hunter DJ, Chen J, et al. A polymorphism of the methionine synthase gene: association with plasma folate, vitamin B12, homocyst(e)ine, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 1999;8:825–829
  99. Macmillan-Crow LA, Cruthirds DL. Invited review: manganese superoxide dismutase in disease. Free Radic Res. 2001;34:325–336
  100. Madigan MP, Ziegler RG, Benichou J, Byrne C, Hoover RN. Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst. 1995;87:1681–1685
  101. Malins DC, Holmes EH, Polissar NL, Gunselman SJ. The etiology of breast cancer. Characteristic alteration in hydroxyl radical-induced DNA base lesions during oncogenesis with potential for evaluating incidence risk. Cancer. 1993;71:3036–3043
  102. Malins DC, Polissar NL, Nishikida K, Holmes EH, Gardner HS, Gunselman SJ. The etiology and prediction of breast cancer. Fourier transform-infrared spectroscopy reveals progressive alterations in breast DNA leading to a cancer-like phenotype in a high proportion of normal women. Cancer. 1995;75:503–517
  103. Martin CA, Mainous AG, Curry T, Martin D. Alcohol use in adolescent females: correlates with estradiol and testosterone. Am J Addict. 1999;8:9–14
  104. Maskarinec G, Lurie G, Williams AE, Le Marchand L. An investigation of mammographic density and gene variants in healthy women. Int J Cancer. 2004;112:683–688
  105. Matsuda T, Kawanishi M, Yagi T, Matsui S, Takebe H. Specific tandem GG to TT base substitutions induced by acetaldehyde are due to intra-strand crosslinks between adjacent guanine bases. Nucleic Acids Res. 1998;26:1769–1774
  106. Matsui A, Ikeda T, Enomoto K, Hosoda K, Nakashima H, Omae K, et al. Increased formation of oxidative DNA damage, 8-hydroxy-2′- deoxyguanosine, in human breast cancer tissue and its relationship to GSTP1 and COMT genotypes. Cancer Lett. 2000;151:87–95
  107. Matsuo K, Suzuki R, Hamajima N, Ogura M, Kagami Y, Taji H, et al. Association between polymorphisms of folate- and methionine-metabolizing enzymes and susceptibility to malignant lymphoma. Blood. 2001;97:3205–3209
  108. McCarver DG. ADH2 and CYP2E1 genetic polymorphisms: risk factors for alcohol-related birth defects. Drug Metab Dispos. 2001;29:562–565
  109. McCarver DG, Byun R, Hines RN, Hichme M, Wegenek W. A genetic polymorphism in the regulatory sequences of human CYP2E1: association with increased chlorzoxazone hydroxylation in the presence of obesity and ethanol intake. Toxicol Appl Pharmacol. 1998;152:276–281
  110. Mezzetti M, La Vecchia C, Decarli A, Boyle P, Talamini R, Franceschi S. Population attributable risk for breast cancer: diet, nutrition, and physical exercise. J Natl Cancer Inst. 1998;90:389–394
  111. Migliore L, Cocchi L, Scarpato R. Detection of the centromere in micronuclei by fluorescence in situ hybridization: its application to the human lymphocyte micronucleus assay after treatment with four suspected aneugens. Mutagenesis. 1996;11:285–290
  112. Millikan RC, Pittman GS, Tse CK, Duell E, Newman B, Savitz D, et al. Catechol-O-methyltransferase and breast cancer risk. Carcinogenesis. 1998;19:1943–1947
  113. Mitrunen K, Jourenkova N, Kataja V, Eskelinen M, Kosma V-M, Benhamou S, et al. Polymorphic catechol-O-methyltransferase gene and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2001;10:635–640
  114. Mitrunen K, Kataja V, Eskelinen M, Kosma V-M, Kang D, Benhamou S, et al. Combined COMT and GST genotypes and hormone replacement therapy associated breast cancer risk. Pharmacogenetics. 2002;12:67–72
  115. Mitrunen K, Sillanpää P, Kataja V, Eskelinen M, Kosma V-M, Benhamou S, et al. Association between manganese superoxide dismutase (MnSOD) gene polymorphism and breast cancer risk. Carcinogenesis. 2001;22:827–829
  116. Miyoshi Y, Ando A, Hasegawa S, Ishitobi M, Yamamura J, Irahara N, et al. Association of genetic polymorphisms in CYP19 and CYP1A1 with the oestrogen receptor-positive breast cancer risk. Eur J Cancer. 2003;39:2531–2537
  117. Miyoshi Y, Iwao K, Ikeda N, Egawa C, Noguchi S. Genetic polymorphism in CYP17 and breast cancer risk in Japanese women. Eur J Cancer. 2000;36:2375–2379
  118. Mobley JA, Bhat AS, Brueggemeier RW. Measurement of oxidative DNA damage by catechol estrogens and analogues in vitro. Chem Res Toxicol. 1999;12:270–277
  119. Moser J, Bagchi D, Akubue PI, Stohs SJ. Excretion of malondialdehyde, formaldehyde, acetaldehyde and acetone in the urine of rats following acute and chronic administration of ethanol. Alcohol Alcohol. 1993;28:287–295
  120. Musarrat J, Arezina-Wilson J, Wani AA. Prognostic and aetiological relevance of 8-hydroxyguanosine in human breast carcinogenesis. Eur J Cancer. 1996;32A:1209–1214
  121. Nagai MA, Schaer Barbosa H, Zago MA, Araújo Silva W, Nishimoto IN, Salaorni S, et al. TP53 mutations in primary breast carcinomas from white and African-Brazilian patients. Int J Oncol. 2003;23:189–196
  122. Nakamura K, Iwahashi K, Furukawa A, Ameno K, Kinoshita H, Ijiri I, et al. Acetaldehyde adducts in the brain of alcoholics. Arch Toxicol. 2003;77:591–593
  123. Navasumrit P, Ward TH, O'Connor PJ, Nair J, Frank N, Bartsch H. Ethanol enhances the formation of endogenously and exogenously derived adducts in rat hepatic DNA. Mutat Res. 2001;479:81–94
  124. Negri E, La Vecchia C, Franceschi S. Re: dietary folate consumption and breast cancer risk. J Natl Cancer Inst. 2000;92:1270–1271
  125. Noori P, Hou S-M. Mutational spectrum induced by acetaldehyde in the HPRT gene of human T lymphocytes resembles that in the p53 gene of esophageal cancers. Carcinogenesis. 2001;22:1825–1830
  126. Olivier M, Hainaut P. TP53 mutation patterns in breast cancers: searching for clues of environmental carcinogenesis. Semin Cancer Biol. 2001;11:353–360
  127. Page S, Powell D, Benboubetra M, Stevens CR, Blake DR, Selase F, et al. Xanthine oxidoreductase in human mammary epithelial cells: activation in response to inflammatory cytokines. Biochim Biophys Acta. 1998;1381:191–202
  128. Pankow JS, Vachon CM, Kuni CC, King RA, Arnett DK, Grabrick DM, et al. Genetic analysis of mammographic breast density in adult women: evidence of a gene effect. J Natl Cancer Inst. 1997;89:549–556
  129. Pastino GM, Flynn EJ, Sultatos LG. Genetic polymorphisms in ethanol metabolism: issues and goals for physiologically based pharmacokinetic modeling. Drug Chem Toxicol. 2000;23:179–201
  130. Paz MF, Avila S, Fraga MF, Pollan M, Capella G, Peinado MA, et al. Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors. Cancer Res. 2002;62:4519–4524
  131. Petri AL, Tjønneland A, Gamborg M, Johansen D, Høidrup S, Sørensen TIA, et al. Alcohol intake, type of beverage, and risk of breast cancer in pre- and postmenopausal women. Alcohol Clin Exp Res. 2004;28:1084–1090
  132. Pfeifer GP. p53 mutational spectra and the role of methylated CpG sequences. Mutat Res. 2000;450:155–166
  133. Pogribny IP, Poirier LA, James SJ. Differential sensitivity to loss of cytosine methyl groups within the hepatic p53 gene of folate/methyl deficient rats. Carcinogenesis. 1995;16:2863–2867
  134. Ratnasinghe D, Tangrea JA, Andersen MR, Barrett MJ, Virtamo J, Taylor PR, et al. Glutathione peroxidase codon 198 polymorphism variant increases lung cancer risk. Cancer Res. 2000;60:6381–6383
  135. Reichman ME, Judd JT, Longcope C, Schatzkin A, Clevidence BA, Nair PP, et al. Effects of alcohol consumption on plasma and urinary hormone concentrations in premenopausal women. J Natl Cancer Inst. 1993;85:722–727
  136. Richard SM, Bailliet G, Páez GL, Bianchi MS, Peltomäki P, Bianchi NO. Nuclear and mitochondrial genome instability in human breast cancer. Cancer Res. 2000;60:4231–4237
  137. Ristow H, Obe G. Acetaldehyde induces cross-links in DNA and causes sister-chromatid exchanges in human cells. Mutat Res. 1978;58:115–119
  138. Ristow H, Seyfarth A, Lochmann E-R. Chromosomal damages by ethanol and acetaldehyde in Saccharomyces cerevisiae as studied by pulsed field gel electrophoresis. Mutat Res. 1995;326:165–170
  139. Rosenblum JS, Gilula NB, Lerner RA. On signal sequence polymorphisms and diseases of distribution. Proc Natl Acad Sci U S A. 1996;93:4471–4473
  140. Rossit ARB, Cabral IR, Hackel C, da Silva RMA, Froes NDTC, Abdel-Rahman SZ. Polymorphisms in the DNA repair gene XRCC1 and susceptibility to alcoholic liver cirrhosis in older Southeastern Brazilians. Cancer Lett. 2002;180:173–182
  141. Russo J, Russo IH. Genotoxicity of steroidal estrogens. Trends Endocrinol Metab. 2004;15:211–214
  142. Rylander-Rudqvist T, Wedrén S, Granath F, Humphreys K, Ahlberg S, Weiderpass E, et al. Cytochrome P450 1B1 gene polymorphisms and postmenopausal breast cancer risk. Carcinogenesis. 2003;24:1533–1539
  143. Sala E, Warren R, McCann J, Duffy S, Luben R, Day N. High-risk mammographic parenchymal patterns, hormone replacement therapy and other risk factors: a case-control study. Int J Epidemiol. 2000;29:629–636
  144. Saleem MM, Al-Tamer YY, Skursky L, Al-Habbal Z. Alcohol dehydrogenase activity in the human tissues. Biochem Med. 1984;31:1–9
  145. Sazci A, Ergul E, Utkan NZ, Canturk NZ, Kaya G. Catechol-O-methyltransferase Val 108/158 Met polymorphism in premenopausal breast cancer patients. Toxicology. 2004;204:197–202
  146. Sellers TA, Grabrick DM, Vierkant RA, Harnack L, Olson JE, Vachon CM, et al. Does folate intake decrease risk of postmenopausal breast cancer among women with a family history?. Cancer Causes Control. 2004;15:113–120
  147. Sellers TA, Kushi LH, Cerhan JR, Vierkant RA, Gapstur SM, Vachon CM, et al. Dietary folate intake, alcohol, and risk of breast cancer in a prospective study of postmenopausal women. Epidemiology. 2001;12:420–428
  148. Shen J-C, Rideout WM, Jones PA. The rate of hydrolytic deamination of 5-methylcytosine in double-stranded DNA. Nucleic Acids Res. 1994;22:972–976
  149. Shields PG, Harris CC. Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. J Clin Oncol. 2000;18:2309–2315
  150. Shimoda-Matsubayashi S, Matsumine H, Kobayashi T, Nakagawa-Hattori Y, Shimizu Y, Mizuno Y. Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's disease. Biochem Biophys Res Commun. 1996;226:561–565
  151. Shrubsole MJ, Gao Y-T, Cai Q, Shu XO, Dai Q, Hébert JR, et al. MTHFR polymorphisms, dietary folate intake, and breast cancer risk: results from the Shanghai Breast Cancer Study. Cancer Epidemiol Biomarkers Prev. 2004;13:190–196
  152. Simão TA, Ribeiro FS, Amorim LMF, Albano RM, Andrada-Serpa MJ, Cardoso LEB, et al. TP53 mutations in breast cancer tumors of patients from Rio de Janeiro, Brazil: association with risk factors and tumor characteristics. Int J Cancer. 2002;101:69–73
  153. Singletary K. Ethanol and experimental breast cancer: a review. Alcohol Clin Exp Res. 1997;21:334–339
  154. Singletary K, Nelshoppen J, Wallig M. Enhancement by chronic ethanol intake of N-methyl-N-nitrosourea-induced rat mammary tumorigenesis. Carcinogenesis. 1995;16:959–964
  155. Singletary KW, Gapstur SM. Alcohol and breast cancer: review of epidemiologic and experimental evidence and potential mechanisms. JAMA. 2001;286:2143–2151
  156. Singletary KW, McNary MQ. Influence of ethanol intake on mammary gland morphology and cell proliferation in normal and carcinogen-treated rats. Alcohol Clin Exp Res. 1994;18:1261–1266
  157. Singletary KW, McNary MQ, Odoms AM, Nelshoppen J, Wallig MA. Ethanol consumption and DMBA-induced mammary carcinogenesis in rats. Nutr Cancer. 1991;16:13–23
  158. Smith-Warner SA, Spiegelman D, Yaun SS, van den Brandt PA, Folsom AR, Goldbohm RA, et al. Alcohol and breast cancer in women: a pooled analysis of cohort studies. JAMA. 1998;279:535–540
  159. Sommer SS, Cunningham J, McGovern RM, Saitoh S, Schroeder JJ, Wold LE, et al. Pattern of p53 gene mutations in breast cancers of women of the midwestern United States. J Natl Cancer Inst. 1992;84:246–252
  160. Spitz MR, Wu X, Wang Y, Wang L-E, Shete S, Amos CI, et al. Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res. 2001;61:1354–1357
  161. Sreerama L, Sladek NE. Identification of the class-3 aldehyde dehydrogenases present in human MCF-7/0 breast adenocarcinoma cells and normal human breast tissue. Biochem Pharmacol. 1994;48:617–620
  162. Stern LL, Mason JB, Selhub J, Choi S-W. Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene. Cancer Epidemiol Biomarkers Prev. 2000;9:849–853
  163. Strömberg P, Svensson S, Hedberg JJ, Nordling E, Höög J-O. Identification and characterisation of two allelic forms of human alcohol dehydrogenase 2. Cell Mol Life Sci. 2002;59:552–559
  164. Sturgis EM, Zheng R, Li L, Castillo EJ, Eicher SA, Chen M, et al. XPD/ERCC2 polymorphisms and risk of head and neck cancer: a case-control analysis. Carcinogenesis. 2000;21:2219–2223
  165. Svegliati-Baroni G, Baraona E, Rosman AS, Lieber CS. Collagen–acetaldehyde adducts in alcoholic and nonalcoholic liver diseases. Hepatology. 1994;20(1 Pt 1):111–118
  166. Tan D-J, Bai R-K, Wong L-JC. Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer. Cancer Res. 2002;62:972–976
  167. Terry MB, Gammon MD, Zhang FF, Eng SM, Sagiv SK, Paykin AB, et al. Polymorphism in the DNA repair gene XPD, polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2004;13:2053–2058
  168. Thomasson HR, Beard JD, Li TK. ADH2 gene polymorphisms are determinants of alcohol pharmacokinetics. Alcohol Clin Exp Res. 1995;19:1494–1499
  169. Thyagarajan B, Brott M, Mink P, Folsom AR, Anderson KE, Oetting WS, et al. CYP1B1 and CYP19 gene polymorphisms and breast cancer incidence: no association in the ARIC study. Cancer Lett. 2004;207:183–189
  170. Triano EA, Slusher LB, Atkins TA, Beneski JT, Gestl SA, Zolfaghari R, et al. Class I alcohol dehydrogenase is highly expressed in normal human mammary epithelium but not in invasive breast cancer: implications for breast carcinogenesis. Cancer Res. 2003;63:3092–3100
  171. Tseng M, Weinberg CR, Umbach DM, Longnecker MP. Calculation of population attributable risk for alcohol and breast cancer (United States). Cancer Causes Control. 1999;10:119–123
  172. Tuma DJ, Casey CA. Dangerous byproducts of alcohol breakdown—focus on adducts. Alcohol Res Health. 2003;27:285–290
  173. Turner RT, Sibonga JD. Effects of alcohol use and estrogen on bone. Alcohol Res Health. 2001;25:276–281
  174. Ursin G, Tseng C-C, Paganini-Hill A, Enger S, Wan PC, Formenti S, et al. Does menopausal hormone replacement therapy interact with known factors to increase risk of breast cancer?. J Clin Oncol. 2002;20:699–706
  175. Vachon CM, King RA, Atwood LD, Kuni CC, Sellers TA. Preliminary sibpair linkage analysis of percent mammographic density. J Natl Cancer Inst. 1999;91:1778–1779
  176. Vachon CM, Kuni CC, Anderson K, Anderson VE, Sellers TA. Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States). Cancer Causes Control. 2000;11:653–662
  177. van der Kooy K, Rookus MA, Peterse HL, van Leeuwen FE. p53 protein overexpression in relation to risk factors for breast cancer. Am J Epidemiol. 1996;144:924–933
  178. van der Put NMJ, van der Molen EF, Kluijtmans LAJ, Heil SG, Trijbels JMF, Eskes TKAB, et al. Sequence analysis of the coding region of human methionine synthase: relevance to hyperhomocysteinaemia in neural-tube defects and vascular disease. QJM. 1997;90:511–517
  179. van Gils CH, Hendriks JHCL, Otten JDM, Holland R, Verbeek ALM. Parity and mammographic breast density in relation to breast cancer risk: indication of interaction. Eur J Cancer Prev. 2000;9:105–111
  180. Verkasalo PK, Thomas HV, Appleby PN, Davey GK, Key TJ. Circulating levels of sex hormones and their relation to risk factors for breast cancer: a cross-sectional study in 1092 pre- and postmenopausal women (United Kingdom). Cancer Causes Control. 2001;12:47–59
  181. Vogelstein B, Kinzler KW. Achilles' heel of cancer?. Nature. 2001;412:865–866
  182. Wang M, Dhingra K, Hittleman WN, Liehr JG, de Andrade M, Li D. Lipid peroxidation-induced putative malondialdehyde-DNA adducts in human breast tissues. Cancer Epidemiol Biomarkers Prev. 1996;5:705–710
  183. Watabiki T, Okii Y, Tokiyasu T, Yoshimura S, Yoshida M, Akane A, et al. Long-term ethanol consumption in ICR mice causes mammary tumor in females and liver fibrosis in males. Alcohol Clin Exp Res. 2000;24(4 Suppl):117S–122S
  184. Wieland P, Lauterburg BH. Oxidation of mitochondrial proteins and DNA following administration of ethanol. Biochem Biophys Res Commun. 1995;213:815–819
  185. Wolfe JN. Breast patterns as an index of risk for developing breast cancer. AJR Am J Roentgenol. 1976;126:1130–1137
  186. Wright RM, McManaman JL, Repine JE. Alcohol-induced breast cancer: a proposed mechanism. Free Radic Biol Med. 1999;26:348–354
  187. Ye Z, Parry JM. The CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis. Mutagenesis. 2002;17:119–126
  188. Yokoyama A, Kato H, Yokoyama T, Tsujinaka T, Muto M, Omori T, et al. Genetic polymorphisms of alcohol and aldehyde dehydrogenases and glutathione S-transferase M1 and drinking, smoking, and diet in Japanese men with esophageal squamous cell carcinoma. Carcinogenesis. 2002;23:1851–1859
  189. Zhang SM. Role of vitamins in the risk, prevention, and treatment of breast cancer. Curr Opin Obstet Gynecol. 2004;16:19–25
  190. Zhang Y, Wise JP, Holford TR, Xie H, Boyle P, Zahm SH, et al. Serum polychlorinated biphenyls, cytochrome P-450 1A1 polymorphisms, and risk of breast cancer in Connecticut women. Am J Epidemiol. 2004;160:1177–1183
  191. Zheng W, Xie D-W, Jin F, Cheng J-R, Dai Q, Wen W-Q, et al. Genetic polymorphism of cytochrome P450-1B1 and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2000;9:147–150

PII: S0741-8329(05)00097-2

doi: 10.1016/j.alcohol.2005.04.005

Alcohol
Volume 35, Issue 3 , Pages 213-225 , April 2005

Article Tools

* Image Usage & Resolution